| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:36 UTC |
|---|
| HMDB ID | HMDB0014382 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Butabarbital |
|---|
| Description | Butabarbital (trade name Butisol) is a prescription barbiturate sleep aid. Butabarbital has a particularly fast onset of effects and short duration of action compared to other barbiturates, which makes it useful for certain applications such as treating severe insomnia and relieving anxiety before surgical procedures; however it is also relatively dangerous particularly when combined with alcohol, and so is now rarely used, although it is still prescribed in some Eastern European and South American countries. Its short duration of action gives butabarbital a high abuse potential, comparable to secobarbital. [Wikipedia ] |
|---|
| Structure | CCC(C)C1(CC)C(=O)NC(=O)NC1=O InChI=1S/C10H16N2O3/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15) |
|---|
| Synonyms | | Value | Source |
|---|
| 5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione | ChEBI | | 5-Ethyl-5-(1-methylpropyl)barbituric acid | ChEBI | | 5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione | ChEBI | | 5-Sec-butyl-5-ethylbarbituric acid | ChEBI | | 5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione | ChEBI | | Butisol | ChEBI | | Secbutabarbital | ChEBI | | 5-Ethyl-5-(1-methylpropyl)barbitate | Generator | | 5-Ethyl-5-(1-methylpropyl)barbitic acid | Generator | | 5-Sec-butyl-5-ethylbarbitate | Generator | | 5-Sec-butyl-5-ethylbarbitic acid | Generator | | Butabarbitone | HMDB | | Butrate | HMDB | | Secbubarbital | HMDB | | Secbutobarbital | HMDB | | Secbutobarbitone | HMDB | | Sodium butabarbital | HMDB | | Secumalum | HMDB | | 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-, monosodium salt | HMDB | | Butisol sodium | HMDB | | Wallace brand OF butabarbital sodium | HMDB | | Butabarbital sodium | HMDB | | Secbutabarbital sodium | HMDB | | Halsey drug brand OF butabarbital sodium | HMDB | | Sarisol | HMDB |
|
|---|
| Chemical Formula | C10H16N2O3 |
|---|
| Average Molecular Weight | 212.2456 |
|---|
| Monoisotopic Molecular Weight | 212.116092388 |
|---|
| IUPAC Name | 5-(butan-2-yl)-5-ethyl-1,3-diazinane-2,4,6-trione |
|---|
| Traditional Name | butabarbital |
|---|
| CAS Registry Number | 125-40-6 |
|---|
| SMILES | CCC(C)C1(CC)C(=O)NC(=O)NC1=O |
|---|
| InChI Identifier | InChI=1S/C10H16N2O3/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15) |
|---|
| InChI Key | ZRIHAIZYIMGOAB-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as barbituric acid derivatives. Barbituric acid derivatives are compounds containing a perhydropyrimidine ring substituted at C-2, -4 and -6 by oxo groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazines |
|---|
| Sub Class | Pyrimidines and pyrimidine derivatives |
|---|
| Direct Parent | Barbituric acid derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Barbiturate
- N-acyl urea
- Ureide
- 1,3-diazinane
- Dicarboximide
- Urea
- Carbonic acid derivative
- Carboxylic acid derivative
- Azacycle
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 166.5 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 1.39 g/L | Not Available | | LogP | 1.5 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.57 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 15.3928 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.62 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 24.3 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2325.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 470.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 167.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 278.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 192.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 581.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 787.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 98.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1206.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 471.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1583.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 372.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 389.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 402.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 345.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 36.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Butabarbital,1TMS,isomer #1 | CCC(C)C1(CC)C(=O)NC(=O)N([Si](C)(C)C)C1=O | 1648.0 | Semi standard non polar | 33892256 | | Butabarbital,1TMS,isomer #1 | CCC(C)C1(CC)C(=O)NC(=O)N([Si](C)(C)C)C1=O | 1814.2 | Standard non polar | 33892256 | | Butabarbital,1TMS,isomer #1 | CCC(C)C1(CC)C(=O)NC(=O)N([Si](C)(C)C)C1=O | 2650.2 | Standard polar | 33892256 | | Butabarbital,2TMS,isomer #1 | CCC(C)C1(CC)C(=O)N([Si](C)(C)C)C(=O)N([Si](C)(C)C)C1=O | 1631.3 | Semi standard non polar | 33892256 | | Butabarbital,2TMS,isomer #1 | CCC(C)C1(CC)C(=O)N([Si](C)(C)C)C(=O)N([Si](C)(C)C)C1=O | 1851.6 | Standard non polar | 33892256 | | Butabarbital,2TMS,isomer #1 | CCC(C)C1(CC)C(=O)N([Si](C)(C)C)C(=O)N([Si](C)(C)C)C1=O | 2201.5 | Standard polar | 33892256 | | Butabarbital,1TBDMS,isomer #1 | CCC(C)C1(CC)C(=O)NC(=O)N([Si](C)(C)C(C)(C)C)C1=O | 1856.5 | Semi standard non polar | 33892256 | | Butabarbital,1TBDMS,isomer #1 | CCC(C)C1(CC)C(=O)NC(=O)N([Si](C)(C)C(C)(C)C)C1=O | 2049.8 | Standard non polar | 33892256 | | Butabarbital,1TBDMS,isomer #1 | CCC(C)C1(CC)C(=O)NC(=O)N([Si](C)(C)C(C)(C)C)C1=O | 2686.1 | Standard polar | 33892256 | | Butabarbital,2TBDMS,isomer #1 | CCC(C)C1(CC)C(=O)N([Si](C)(C)C(C)(C)C)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 2042.4 | Semi standard non polar | 33892256 | | Butabarbital,2TBDMS,isomer #1 | CCC(C)C1(CC)C(=O)N([Si](C)(C)C(C)(C)C)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 2297.2 | Standard non polar | 33892256 | | Butabarbital,2TBDMS,isomer #1 | CCC(C)C1(CC)C(=O)N([Si](C)(C)C(C)(C)C)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 2357.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Butabarbital GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a7i-8900000000-fc5f17ec8979e31b77ac | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Butabarbital GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-0a4l-6900000000-6e0cbc3d26c5541ad8eb | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 10V, Positive-QTOF | splash10-03di-1290000000-73748d3c96bdcbc7692d | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 20V, Positive-QTOF | splash10-0007-3900000000-c62b6d06318be5ee7a26 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 40V, Positive-QTOF | splash10-0a4i-9000000000-d815b39070a4a2b620ee | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 10V, Negative-QTOF | splash10-0296-8950000000-e8d3b0ea461e5ad69068 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 20V, Negative-QTOF | splash10-0006-9500000000-43d75b9170cae3f239fa | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 40V, Negative-QTOF | splash10-000x-9400000000-ec7399384bd48aaa6ee4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 10V, Positive-QTOF | splash10-0a4i-0900000000-121a04bb64c32af4a00f | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 20V, Positive-QTOF | splash10-0a4i-3900000000-58caeb294d4571a30cf4 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 40V, Positive-QTOF | splash10-0002-9300000000-527f2d60d78505d84953 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 10V, Negative-QTOF | splash10-03di-1290000000-994157d74b9e27e50e2d | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 20V, Negative-QTOF | splash10-0006-9000000000-90726b17dc36e29c5299 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butabarbital 40V, Negative-QTOF | splash10-0006-9100000000-85bbea89298999fca7c3 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|